High	0	4	O
-	4	5	O
grade	5	10	O
clear	11	16	B-Pathological_formation
cell	17	21	I-Pathological_formation
renal	22	27	I-Pathological_formation
cell	28	32	I-Pathological_formation
carcinoma	33	42	I-Pathological_formation
has	43	46	O
a	47	48	O
higher	49	55	O
angiogenic	56	66	O
activity	67	75	O
than	76	80	O
low	81	84	O
-	84	85	O
grade	85	90	O
renal	91	96	B-Pathological_formation
cell	97	101	I-Pathological_formation
carcinoma	102	111	I-Pathological_formation
based	112	117	O
on	118	120	O
histomorphological	121	139	O
quantification	140	154	O
and	155	158	O
qRT	159	162	O
-	162	163	O
PCR	163	166	O
mRNA	167	171	O
expression	172	182	O
profile	183	190	O
.	190	191	O

Clear	193	198	B-Pathological_formation
cell	199	203	I-Pathological_formation
renal	204	209	I-Pathological_formation
cell	210	214	I-Pathological_formation
carcinoma	215	224	I-Pathological_formation
(	225	226	O
CC	226	228	B-Pathological_formation
-	228	229	I-Pathological_formation
RCC	229	232	I-Pathological_formation
)	232	233	O
is	234	236	O
a	237	238	O
highly	239	245	O
vascularised	246	258	O
tumour	259	265	B-Pathological_formation
and	266	269	O
is	270	272	O
therefore	273	282	O
an	283	285	O
attractive	286	296	O
disease	297	304	O
to	305	307	O
study	308	313	O
angiogenesis	314	326	O
and	327	330	O
to	331	333	O
test	334	338	O
novel	339	344	O
angiogenesis	345	357	O
inhibitors	358	368	O
in	369	371	O
early	372	377	O
clinical	378	386	O
development	387	398	O
.	398	399	O

Endothelial	400	411	B-Cell
cell	412	416	I-Cell
proliferation	417	430	O
plays	431	436	O
a	437	438	O
pivotal	439	446	O
role	447	451	O
in	452	454	O
the	455	458	O
process	459	466	O
of	467	469	O
angiogenesis	470	482	O
.	482	483	O

The	484	487	O
aim	488	491	O
of	492	494	O
this	495	499	O
study	500	505	O
was	506	509	O
to	510	512	O
compare	513	520	O
angiogenesis	521	533	O
parameters	534	544	O
in	545	547	O
low	548	551	O
nuclear	552	559	O
grade	560	565	O
(	566	567	O
n	567	568	O
=	568	569	O
87	569	571	O
)	571	572	O
vs	573	575	O
high	576	580	O
nuclear	581	588	O
grade	589	594	O
CC	595	597	B-Pathological_formation
-	597	598	I-Pathological_formation
RCC	598	601	I-Pathological_formation
(	602	603	O
n	603	604	O
=	604	605	O
63	605	607	O
)	607	608	O
.	608	609	O

A	610	611	O
panel	612	617	O
of	618	620	O
antibodies	621	631	O
was	632	635	O
used	636	640	O
for	641	644	O
immunohistochemistry	645	665	O
:	665	666	O
CD34	667	671	B-Gene_or_gene_product
/	671	672	O
Ki	672	674	B-Gene_or_gene_product
-	674	675	I-Gene_or_gene_product
67	675	677	I-Gene_or_gene_product
,	677	678	O
carbonic	679	687	B-Gene_or_gene_product
anhydrase	688	697	I-Gene_or_gene_product
IX	698	700	I-Gene_or_gene_product
,	700	701	O
hypoxia	702	709	B-Gene_or_gene_product
-	709	710	I-Gene_or_gene_product
inducible	710	719	I-Gene_or_gene_product
factor	720	726	I-Gene_or_gene_product
-	726	727	I-Gene_or_gene_product
1alpha	727	733	I-Gene_or_gene_product
(	734	735	O
HIF	735	738	B-Gene_or_gene_product
-	738	739	I-Gene_or_gene_product
1alpha	739	745	I-Gene_or_gene_product
)	745	746	O
and	747	750	O
vascular	751	759	B-Gene_or_gene_product
endothelial	760	771	I-Gene_or_gene_product
growth	772	778	I-Gene_or_gene_product
factor	779	785	I-Gene_or_gene_product
(	786	787	O
VEGF	787	791	B-Gene_or_gene_product
)	791	792	O
.	792	793	O

Vessel	794	800	B-Multi-tissue_structure
density	801	808	O
(	809	810	O
MVD	810	813	O
-	814	815	O
microvessel	816	827	B-Tissue
density	828	835	O
)	835	836	O
,	836	837	O
endothelial	838	849	B-Cell
cell	850	854	I-Cell
proliferation	855	868	O
fraction	869	877	O
(	878	879	O
ECP	879	882	O
%	882	883	O
)	883	884	O
and	885	888	O
tumour	889	895	B-Cell
cell	896	900	I-Cell
proliferation	901	914	O
fraction	915	923	O
(	924	925	O
TCP	925	928	O
%	928	929	O
)	929	930	O
were	931	935	O
assessed	936	944	O
.	944	945	O

mRNA	946	950	O
expression	951	961	O
levels	962	968	O
of	969	971	O
angiogenesis	972	984	O
stimulators	985	996	O
and	997	1000	O
inhibitors	1001	1011	O
were	1012	1016	O
determined	1017	1027	O
by	1028	1030	O
quantitative	1031	1043	O
RT	1044	1046	O
-	1046	1047	O
PCR	1047	1050	O
.	1050	1051	O

High	1052	1056	O
-	1056	1057	O
grade	1057	1062	O
CC	1063	1065	B-Pathological_formation
-	1065	1066	I-Pathological_formation
RCC	1066	1069	I-Pathological_formation
showed	1070	1076	O
a	1077	1078	O
higher	1079	1085	O
ECP	1086	1089	O
%	1089	1090	O
(	1091	1092	O
P	1092	1093	O
=	1093	1094	O
0	1094	1095	O
.	1095	1096	O
049	1096	1099	O
)	1099	1100	O
,	1100	1101	O
a	1102	1103	O
higher	1104	1110	O
TCP	1111	1114	O
%	1114	1115	O
(	1116	1117	O
P	1117	1118	O
=	1118	1119	O
0	1119	1120	O
.	1120	1121	O
009	1121	1124	O
)	1124	1125	O
,	1125	1126	O
a	1127	1128	O
higher	1129	1135	O
VEGF	1136	1140	B-Gene_or_gene_product
protein	1141	1148	O
expression	1149	1159	O
(	1160	1161	O
P	1161	1162	O
less	1163	1167	O
than	1168	1172	O
0	1173	1174	O
.	1174	1175	O
001	1175	1178	O
)	1178	1179	O
,	1179	1180	O
a	1181	1182	O
lower	1183	1188	O
MVD	1189	1192	O
(	1193	1194	O
P	1194	1195	O
less	1196	1200	O
than	1201	1205	O
0	1207	1208	O
.	1208	1209	O
001	1209	1212	O
)	1212	1213	O
and	1214	1217	O
a	1218	1219	O
lower	1220	1225	O
HIF	1226	1229	B-Gene_or_gene_product
-	1229	1230	I-Gene_or_gene_product
1alpha	1230	1236	I-Gene_or_gene_product
protein	1237	1244	O
expression	1245	1255	O
(	1256	1257	O
P	1257	1258	O
=	1258	1259	O
0	1259	1260	O
.	1260	1261	O
002	1261	1264	O
)	1264	1265	O
than	1266	1270	O
low	1271	1274	O
-	1274	1275	O
grade	1275	1280	O
CC	1281	1283	B-Pathological_formation
-	1283	1284	I-Pathological_formation
RCC	1284	1287	I-Pathological_formation
.	1287	1288	O

Growth	1289	1295	O
factor	1296	1302	O
mRNA	1303	1307	O
expression	1308	1318	O
analyses	1319	1327	O
revealed	1328	1336	O
a	1337	1338	O
higher	1339	1345	O
expression	1346	1356	O
of	1357	1359	O
angiopoietin	1360	1372	B-Gene_or_gene_product
2	1373	1374	I-Gene_or_gene_product
in	1375	1377	O
low	1378	1381	O
-	1381	1382	O
grade	1382	1387	O
CC	1388	1390	B-Pathological_formation
-	1390	1391	I-Pathological_formation
RCC	1391	1394	I-Pathological_formation
.	1394	1395	O

Microvessel	1396	1407	B-Tissue
density	1408	1415	O
and	1416	1419	O
ECP	1420	1423	O
%	1423	1424	O
were	1425	1429	O
inversely	1430	1439	O
correlated	1440	1450	O
(	1451	1452	O
Rho	1452	1455	O
=	1455	1456	O
-	1456	1457	O
0	1457	1458	O
.	1458	1459	O
26	1459	1461	O
,	1461	1462	O
P	1463	1464	O
=	1464	1465	O
0	1465	1466	O
.	1466	1467	O
001	1467	1470	O
)	1470	1471	O
.	1471	1472	O

Because	1473	1480	O
of	1481	1483	O
the	1484	1487	O
imperfect	1488	1497	O
association	1498	1509	O
of	1510	1512	O
nuclear	1513	1520	O
grade	1521	1526	O
and	1527	1530	O
ECP	1531	1534	O
%	1534	1535	O
or	1536	1538	O
MVD	1539	1542	O
,	1542	1543	O
CC	1544	1546	B-Pathological_formation
-	1546	1547	I-Pathological_formation
RCC	1547	1550	I-Pathological_formation
was	1551	1554	O
also	1555	1559	O
grouped	1560	1567	O
based	1568	1573	O
on	1574	1576	O
low	1577	1580	O
/	1580	1581	O
high	1581	1585	O
MVD	1586	1589	O
and	1590	1593	O
ECP	1594	1597	O
%	1597	1598	O
.	1598	1599	O

This	1600	1604	O
analysis	1605	1613	O
revealed	1614	1622	O
a	1623	1624	O
higher	1625	1631	O
expression	1632	1642	O
of	1643	1645	O
vessel	1646	1652	B-Multi-tissue_structure
maturation	1653	1663	O
and	1664	1667	O
stabilisation	1668	1681	O
factors	1682	1689	O
(	1690	1691	O
placental	1691	1700	B-Gene_or_gene_product
growth	1701	1707	I-Gene_or_gene_product
factor	1708	1714	I-Gene_or_gene_product
,	1714	1715	O
PDGFB1	1716	1722	B-Gene_or_gene_product
,	1722	1723	O
angiopoietin	1724	1736	B-Gene_or_gene_product
1	1737	1738	I-Gene_or_gene_product
)	1738	1739	O
in	1740	1742	O
CC	1743	1745	B-Pathological_formation
-	1745	1746	I-Pathological_formation
RCC	1746	1749	I-Pathological_formation
with	1750	1754	O
high	1755	1759	O
MVD	1760	1763	O
,	1763	1764	O
a	1765	1766	O
group	1767	1772	O
of	1773	1775	O
CC	1776	1778	B-Pathological_formation
-	1778	1779	I-Pathological_formation
RCC	1779	1782	I-Pathological_formation
highly	1783	1789	O
enriched	1790	1798	O
in	1799	1801	O
low	1802	1805	O
nuclear	1806	1813	O
grade	1814	1819	O
CC	1820	1822	B-Pathological_formation
-	1822	1823	I-Pathological_formation
RCC	1823	1826	I-Pathological_formation
,	1826	1827	O
with	1828	1832	O
low	1833	1836	O
ECP	1837	1840	O
%	1840	1841	O
.	1841	1842	O

Our	1843	1846	O
results	1847	1854	O
suggest	1855	1862	O
heterogeneity	1863	1876	O
in	1877	1879	O
angiogenic	1880	1890	O
activity	1891	1899	O
and	1900	1903	O
vessel	1904	1910	B-Multi-tissue_structure
maturation	1911	1921	O
of	1922	1924	O
CC	1925	1927	B-Pathological_formation
-	1927	1928	I-Pathological_formation
RCC	1928	1931	I-Pathological_formation
,	1931	1932	O
to	1933	1935	O
a	1936	1937	O
large	1938	1943	O
extent	1944	1950	O
linked	1951	1957	O
to	1958	1960	O
nuclear	1961	1968	O
grade	1969	1974	O
,	1974	1975	O
and	1976	1979	O
,	1979	1980	O
with	1981	1985	O
probable	1986	1994	O
therapeutic	1995	2006	O
implications	2007	2019	O
.	2019	2020	O

